Researchers evaluate imaging information and characterize skeletal proportions to assess the genetic root of these traits and their connections to each other.
Lilly’s oral cardio drug that blocks lipids passes mid-stage test
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS